2021 American Transplant Congress
The Gut Microbiota Diversity and Metabolite Production is Reduced in Liver Transplant Recipients and Associated with Post-Operative Infection
University of Chicago, Chicago, IL
*Purpose: Liver transplant (LT) recipients have abnormal microbiota before and after transplantation. (1,2) The association between fecal microbiota, metabolites, and clinical outcomes in liver transplantation…2021 American Transplant Congress
Kidney Transplant Outcomes in HIV+ Recipients: A Single-Center Study
1Medicine, Edward Hines VA, Hines, IL, 2Medicine, University of Illinois, Chicago, IL
*Purpose: HIV+ patients are eligible to recieve a kidney transplant (KT) provided they meet criteria of undetectable viral load (VL) and CD4 count >200. We…2021 American Transplant Congress
Clinical Characteristics, Risk Factors and Outcomes of Norovirus Infection in Renal Transplant Patients: A Retrospective Single Center Study
*Purpose: Norovirus gastrointestinal infection has been identified as a cause of significant morbidity among immunocompromised hosts, particularly hematopoietic stem cell transplant (HSCT) and solid organ…2021 American Transplant Congress
Discontinuation of Trimethoprim/sulfamethoxazole Prophylaxis Due to Hyperkalemia in Kidney Transplant Recipients
*Purpose: Trimethoprim-sulfamethoxazole (TMP-SMX) is the drug of choice for Pneumocystis jirovecii pneumonia (PJP) prophylaxis in kidney transplant recipients (KTRs), however, it can be complicated by…2021 American Transplant Congress
Polyomavirus BK-Associated Nephropathy in Patients After Renal and Extrarenal Transplantation
*Purpose: Patients with non-renal organ transplantation (TX) may suffer BK-viral nephropathy (BKVN) of their own orthotopic kidneys. We aimed to know if these patients with…2021 American Transplant Congress
Effect of HLA-DR Mismatches on Graft Outcomes of Kidney Transplant from Elderly Donors
David Geffen School of Medicine at UCLA, Los Angeles, CA
*Purpose: Human leukocyte antigen (HLA)-DR has been shown to be more immunogenic than HLA-A or -B. The impact of HLA-DR mismatches remains unclear among kidney…2021 American Transplant Congress
Effect of Donor Glomerulosclerosis and Interstitial Fibrosis/Tubular Atrophy (IFTA) on Kidney Graft Survival: A Single Organ Procurement Organization (OPO) Data
1Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 2OneLegacy, Los Angeles, CA
*Purpose: The kidneys of deceased donors are often biopsied to evaluate transplant organ quality. A high percentage of GS is a leading cause of kidney…2021 American Transplant Congress
Prolonged Cold Ischemic Time Demonstrating Minor Effect on Outcomes Following Renal Transplantation – A Paired Kidney Analysis
1Columbia University Irving Medical Center, New York, NY, 2Columbia University, New York, NY
*Purpose: An improved understanding of the effects of cold ischemia time (CIT) on deceased donor kidney (DDK) outcomes may increase organ utilization by clarifying the…2021 American Transplant Congress
Association of Kidney Function with Patient Reported Outcomes After Kidney Transplantation
Nephrology, Vanderbilt University Medical Center, Nashville, TN
*Purpose: Our study aimed to determine the association of posttransplant eGFR with patient reported outcomes (PROs) and, specifically, the risk of reduced health-related quality of…2021 American Transplant Congress
Continuous 24-Hour Antithymocyte Globulin (ATG) for Renal Allograft Rejection: Results of a Randomized Controlled Trial
Houston Methodist Hospital, Houston, TX
*Purpose: For acute renal allograft rejection (AR), ATG is generally administered in the inpatient setting because of the need for intravenous access, patient monitoring, and…
American Transplant Congress abstracts